YP Biotech

YURiA-PHARM is a Ukrainian pharmaceutical group of companies with over 30-years of experience in development and production of therapeutics and medical devices. In 2015, we established a unique for Ukraine innovative R&D center focusing on biopharmaceutical research and development. Our work is enabled by a powerful set of technologies that cover all stages of the development cycle: from biomolecule design to pilot production of a therapeutic product. Our platforms include a broad range of synthetic biology approaches, a process development pipeline and an analytical toolkit for extensive product characterization and QC. Our fundamental and applied research in the field of recombinant proteins and nucleic acid-based therapeutics provide the basis for development of first-in-class medicines for complex and hard-to-treat diseases. Having created the most advanced multi-purpose infrastructure for biomedical research in Ukraine, we aim to transform our corporate R&D center into an R&D Hub that will provide opportunities for scientists from around the world to develop next generation therapeutics meant to save and improve patients’ lives.